Google Unveils New AI Models for Drug Discovery

At a health-focused event in New York on Tuesday, Google unveiled its latest project, TxGemma, a set of "open" AI models aimed at revolutionizing drug discovery. These models, set to be released through Google's Health AI Developer Foundations program later this month, are designed to process both standard text and the intricate structures of various therapeutic entities such as chemicals, molecules, and proteins.
Karen DeSalvo, Google's chief health officer, emphasized the potential impact of TxGemma in a blog post shared with TechCrunch. She noted, "The development of therapeutic drugs from concept to approved use is a long and expensive process, so we're working with the wider research community to find new ways to make this development more efficient." Researchers can leverage TxGemma to predict crucial properties of potential new therapies, such as their safety and effectiveness.
However, Google has not yet clarified whether the licensing for these models will permit commercial use, customization, or fine-tuning. TechCrunch has reached out for further details and will update the story if Google responds.
The promise of AI transforming drug discovery is not new. Numerous companies, including Google's own spin-out Isomorphic Labs, have touted AI's potential to speed up the initial stages of research and development. Despite some successes, AI has yet to deliver a complete solution in the lab. High-profile clinical trial failures have plagued companies like Exscientia and BenevolentAI in recent years, and the accuracy of leading AI systems like Google DeepMind's AlphaFold 3 can be inconsistent.
Despite these challenges, both big pharma and investors remain optimistic about AI's future in drug discovery. Isomorphic Labs, with its partnerships with Eli Lilly and Novartis, anticipates beginning testing on its AI-designed drugs this year. The sector is bustling with activity, with over 460 AI startups focused on drug discovery and investors having committed around $60 billion to the field so far.
Related article
Google AI Overviews Gain Ground in Search Results
According to Similarweb’s 2026 Generative AI Landscape report, Google’s AI-generated summaries appeared in 43% of US searches, a significant rise from 15% recorded a year prior.While AI Overviews present generated summaries within standard search res
Google to Pay SpaceX $920M Monthly for Compute
SpaceX has secured another major compute agreement ahead of its landmark IPO, this time partnering with Google. The company disclosed the arrangement in a regulatory filing on Friday.According to the agreement, Google will pay SpaceX $920 million mon
Google expands AI Mode to track flight prices and book hotels
Google has introduced new capabilities within AI Mode, its conversational search interface, allowing users to plan and book trips more effectively, the company revealed on Thursday. The updated features enable users to inquire about flight price tren
Related Special Topic Recommendations
Comments (32)
0/500
This is wild! Google's AI diving into drug discovery with TxGemma sounds like sci-fi coming to life. Can't wait to see how it shakes up the pharma world! 😎
Super cool to see Google diving into drug discovery with TxGemma! 😮 Wonder how fast these AI models can churn out new meds compared to old-school lab work?
El TxGemma de Google es una herramienta revolucionaria para el descubrimiento de fármacos. ¡Es increíble que pueda procesar datos estructurados y no estructurados! La única desventaja es el tiempo de espera para el lanzamiento completo. ¡No puedo esperar para ver qué avances trae! 🚀
GoogleのTxGemmaは薬の発見に革命をもたらすツールですね!構造化データと非構造化データの両方を処理できるなんて素晴らしい。ただ、完全リリースまでの待ち時間が少し長いかな。どんなブレークスルーが生まれるのか楽しみです!🚀
Google's new AI models for drug discovery sound promising, but I'm skeptical about how 'open' they really are. Still, if they can speed up drug development, that's a big win. Let's see how it pans out! 🤔

Google AI Overviews Gain Ground in Search Results
According to Similarweb’s 2026 Generative AI Landscape report, Google’s AI-generated summaries appeared in 43% of US searches, a significant rise from 15% recorded a year prior.While AI Overviews present generated summaries within standard search res
Google to Pay SpaceX $920M Monthly for Compute
SpaceX has secured another major compute agreement ahead of its landmark IPO, this time partnering with Google. The company disclosed the arrangement in a regulatory filing on Friday.According to the agreement, Google will pay SpaceX $920 million mon
Google expands AI Mode to track flight prices and book hotels
Google has introduced new capabilities within AI Mode, its conversational search interface, allowing users to plan and book trips more effectively, the company revealed on Thursday. The updated features enable users to inquire about flight price tren
This is wild! Google's AI diving into drug discovery with TxGemma sounds like sci-fi coming to life. Can't wait to see how it shakes up the pharma world! 😎
Super cool to see Google diving into drug discovery with TxGemma! 😮 Wonder how fast these AI models can churn out new meds compared to old-school lab work?
El TxGemma de Google es una herramienta revolucionaria para el descubrimiento de fármacos. ¡Es increíble que pueda procesar datos estructurados y no estructurados! La única desventaja es el tiempo de espera para el lanzamiento completo. ¡No puedo esperar para ver qué avances trae! 🚀
GoogleのTxGemmaは薬の発見に革命をもたらすツールですね!構造化データと非構造化データの両方を処理できるなんて素晴らしい。ただ、完全リリースまでの待ち時間が少し長いかな。どんなブレークスルーが生まれるのか楽しみです!🚀
Google's new AI models for drug discovery sound promising, but I'm skeptical about how 'open' they really are. Still, if they can speed up drug development, that's a big win. Let's see how it pans out! 🤔





Home






